Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

NPR's Ari Shapiro talks with Dr. Jennifer Avegno, director of the New Orleans Health Department, about a new map created to help patients find the restricted reproductive health drug misoprostol.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

It's no secret that Americans are frustrated with what they're paying for prescription drugs. Most people blame drug ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds marbaloxavir and favipiravir while removing amantadine and rimantadine.

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...